Ticker Details
Codexis, Inc. Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.
IPO Date:	April 22, 2010
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$182.87M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.13%
Avg Daily Range (30 D):	$0.08 | 4.35%
Avg Daily Range (90 D):	$0.10 | 4.34%

Institutional Daily Volume
Avg Daily Volume:	.39M
Avg Daily Volume (30 D):	1.21M
Avg Daily Volume (90 D):	1M

Trade Size
Avg Trade Size (Sh.):	122
Avg Trade Size (Sh.) (30 D):	190
Avg Trade Size (Sh.) (90 D):	151

Institutional Trades
Total Institutional Trades:	1,273
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$1.4M
Avg Institutional Trade (90 D):	$1.19M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.28M
Avg Closing Trade (30 D):	$.92M
Avg Closing Trade (90 D):	$1.15M
Avg Closing Volume:	96.74K

News

Jul 24, 2026 @ 3:47 AM Codexis Announces Pricing of Public Offering of Co... Source: Na

Aug 28, 2025 @ 1:00 PM Codexis to Participate in Cantor Global Healthcare... Source: Georgia Erbez

May 22, 2025 @ 11:00 AM Codexis’ Landmark Presentations at TIDES US... Source: N/A

Apr 9, 2025 @ 9:00 PM Codexis Announces Byron Dorgan to Retire from Boar... Source: N/A

Feb 20, 2025 @ 3:00 PM Specialty Enzymes Market to Expand at 7.5% CAGR, R... Source: Sns Insider

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.33	$-.13	$-.1
Diluted EPS	$-.33	$-.13	$-.1
Revenue	$77.68M	$14.92M	$15.25M
Gross Profit	$67.6M	$11.4M	$13.18M
Net Income / Loss	$-30.72M	$-12.01M	$-8.7M
Operating Income / Loss	$-27.66M	$-11.23M	$-8.04M
Cost of Revenue	$10.08M	$3.51M	$2.06M
Net Cash Flow	$.88M	$-9.4M	$-14.28M
PE Ratio